Satoru Noguchi Selected Research

Satoru Noguchi Research Topics

Disease

30	Muscular Diseases (Myopathy) 01/2022 - 12/2004
13	Nonaka type Distal myopathy 06/2014 - 03/2004
10	Muscular Dystrophies (Muscular Dystrophy) 02/2017 - 03/2003
6	Muscle Weakness 01/2022 - 11/2009
6	Distal Myopathies (Distal Muscular Dystrophy) 02/2017 - 12/2004
5	Muscular Atrophy (Muscle Atrophy) 01/2017 - 06/2009
4	Congenital Structural Myopathies (Centronuclear Myopathy) 06/2022 - 02/2015
4	Necrosis 01/2022 - 03/2003
4	Atrophy 01/2022 - 09/2008
4	Scleroatonic muscular dystrophy 01/2021 - 09/2008
4	Walker-Warburg Syndrome 11/2006 - 06/2004
3	Contracture 02/2022 - 01/2021
3	Dermatomyositis (Dermatopolymyositis) 01/2022 - 01/2020
3	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 01/2021 - 03/2003
3	Malignant Hyperthermia 01/2021 - 06/2006
3	Limb-girdle muscular dystrophy type 2A 11/2014 - 05/2003
3	Limb-Girdle Muscular Dystrophies (Limb-Girdle Muscular Dystrophy) 07/2007 - 05/2003
2	Myositis (Idiopathic Inflammatory Myopathies) 01/2022 - 01/2020
2	Melanoma (Melanoma, Malignant) 01/2022 - 01/2020
2	Fibrosis (Cirrhosis) 01/2021 - 02/2017
2	Minicore Myopathy with External Ophthalmoplegia 01/2016 - 06/2006
2	Central Core Myopathy (Central Core Disease) 06/2006 - 06/2006
1	distal type 1 Arthrogryposis multiplex congenita 02/2022
1	Thrombocytopenia (Thrombopenia) 01/2022
1	Neuronal intranuclear inclusion disease 01/2022
1	Sleep Apnea Syndromes (Sleep Apnea) 01/2022
1	Heat Stroke (Heatstroke) 01/2021
1	Aspiration Pneumonia 01/2021
1	Inborn Genetic Diseases (Disease, Hereditary) 01/2021
1	Bethlem myopathy 01/2021
1	With Uniform Type 1 Fiber Congenital Neuromuscular Disease 12/2020
1	Dysarthria (Spastic Dysarthria) 11/2020
1	Ophthalmoplegia (External Ophthalmoplegia) 11/2020

Drug/Important Bio-Agent (IBA)

15	N-Acetylneuraminic Acid (Sialic Acid)IBA 01/2022 - 03/2004
12	Proteins (Proteins, Gene)FDA Link 03/2017 - 03/2003
8	EnzymesIBA 01/2022 - 03/2004
6	Uridine Diphosphate (UDP)IBA 02/2017 - 03/2004
6	Racemases and Epimerases (Epimerases and Racemases)IBA 02/2017 - 03/2004
6	N-acylmannosamine kinaseIBA 05/2014 - 03/2004
5	Dystroglycans (Dystroglycan)IBA 11/2006 - 06/2004
4	Ryanodine Receptor Calcium Release Channel (Ryanodine Receptor)IBA 01/2021 - 06/2006
4	CollagenIBA 01/2021 - 09/2008
3	UDP acetylglucosamine-2-epimeraseIBA 01/2022 - 11/2009
3	Phosphotransferases (Kinase)IBA 02/2017 - 03/2004
3	SugarsIBA 01/2012 - 03/2010
3	LaminsIBA 06/2011 - 01/2009
3	AcetylglucosamineIBA 11/2007 - 03/2004
2	Dynamin IIIBA 06/2022 - 01/2021
2	Creatine Kinase (Creatine Phosphokinase)IBA 02/2022 - 01/2013
2	Mi-2 antibodiesIBA 01/2022 - 01/2021
2	Complement Membrane Attack Complex (Membrane Attack Complex)IBA 01/2022 - 01/2021
2	UbiquitinIBA 01/2022 - 01/2020
2	Staphylococcal Protein A (Protein A)IBA 01/2022 - 01/2020
2	nuclear matrix protein 2IBA 01/2022 - 01/2020
2	Alkaline PhosphataseIBA 01/2022 - 01/2021
2	AntibodiesIBA 01/2022 - 11/2020
2	AutoantibodiesIBA 01/2021 - 01/2020
2	LectinsIBA 08/2018 - 03/2004
2	N,N-diacetylchitobioseIBA 02/2017 - 03/2004
2	CalciumIBA 11/2016 - 06/2006
2	DNA (Deoxyribonucleic Acid)IBA 04/2016 - 05/2015
2	N-acetylneuraminoyllactoseIBA 10/2014 - 01/2012
2	Messenger RNA (mRNA)IBA 06/2014 - 04/2007
2	Amyloid beta-PeptidesIBA 06/2014 - 10/2008
2	Glucosamine (Dona)IBA 05/2014 - 07/2012
2	Choline KinaseIBA 10/2011 - 06/2011
2	emerinIBA 06/2011 - 07/2007
2	Amyloid (Amyloid Fibrils)IBA 11/2009 - 06/2009
2	LipidsIBA 03/2009 - 08/2008
2	Complementary DNA (cDNA)IBA 04/2007 - 03/2003
1	Amino Acids FDA Link 02/2022
1	TropomyosinIBA 02/2022
1	Troponin IIBA 02/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	Coloring Agents (Dyes)IBA 01/2022
1	transcriptional intermediary factor 1IBA 01/2022
1	Nucleosomes (Nucleosome)IBA 01/2022
1	Histone Deacetylases (Histone Deacetylase)IBA 01/2022
1	HLA-DR Antigens (HLA-DR)IBA 01/2022
1	Succimer (Dimercaptosuccinic Acid)FDA Link 01/2022
1	Immunoglobulin G (IgG)IBA 01/2022
1	Indicators and Reagents (Reagents)IBA 01/2022
1	2-methylcyclopentadienyl manganese tricarbonyl (MMT)IBA 01/2022
1	Isoflurane FDA LinkGeneric 01/2021
1	CationsIBA 01/2021
1	Oxolinic AcidIBA 01/2021
1	CDN1163IBA 01/2021
1	Caffeine (No Doz)FDA LinkGeneric 01/2021
1	AcidsIBA 01/2021
1	Halothane (Fluothane)FDA Link 01/2021
1	DystrophinIBA 01/2021
1	triadinIBA 12/2020
1	Myosins (Myosin)IBA 12/2020
1	Ubiquitinated ProteinsIBA 11/2020

Therapy/Procedure

9	Therapeutics 01/2020 - 01/2007
1	Continuous Positive Airway Pressure 01/2022
1	Cell Transplantation 01/2021
1	Anesthesia 01/2021
1	Artificial Respiration (Mechanical Ventilation) 01/2021
1	Transplantation 01/2021